E

Exelixis

D

EXEL

USD

0.22

(0.8206%)

مفتوح الان

48,280.00

حجم التداول

1.385

الربح لكل سهم

-

العائد الربحي

23.216

P/E

7,680,402,695.63

حجم السوق

اليوم

0.4476%

1 اسبوع

1.165%

1 شهر

2.240%

6 اشهر

16.228%

12 اشهر

26.254%

بداية السنة

12.232%

كل الوقت

0%

أصول ذات صلة

أفضل المتداولين

Title:
Exelixis

Sector:

Healthcare

Industry:

Biotechnology

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا